Citadel Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $936K | Buy |
|
|||||
|
2025
Q1 | $682K | Sell |
|
|||||
|
2024
Q4 | $1.74M | Sell |
|
|||||
|
2024
Q3 | $3.61M | Buy |
|
|||||
|
2024
Q2 | $3.16M | Buy |
|
|||||
|
2024
Q1 | $1.92M | Sell |
|
|||||
|
2023
Q4 | $938K | Sell |
|
|||||
|
2023
Q3 | $2.26M | Buy |
|
|||||
|
2023
Q2 | $214K | Sell |
|
|||||
|
2023
Q1 | $1.53M | Sell |
|
|||||
|
2022
Q4 | $4.69M | Buy |
|
|||||
|
2022
Q3 | $1.3M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $320K | Sell |
|
|||||
|
2021
Q4 | $2.04M | Buy |
|
|||||
|
2021
Q3 | $2.98M | Sell |
|
|||||
|
2021
Q2 | $5.92M | Buy |
|
|||||
|
2021
Q1 | $2.76M | Sell |
|
|||||
|
2020
Q4 | $5.72M | Buy |
|
|||||
|
2020
Q3 | $352K | Sell |
|
|||||
|
2020
Q2 | $561K | Sell |
|
|||||
|
2020
Q1 | $990K | Sell |
|
|||||
|
2019
Q4 | $2.2M | Buy |
|